Company
Capso Vision
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
0
510(k), De Novo and PMA
Device trials
7
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
3
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Capso Vision, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Capso Vision.
Latest FDA decisions
No 510(k), De Novo or PMA decisions under this name since 2015.
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy ReferencePivotal-lookingRecruiting
NCT07089615 · 330 participants (planned) · Start Jun 26, 2025 · Primary completion Dec 2026
Device: Capsule swallow · For: Colonic Polyps
Sites: Chula Vista, California; Lancaster, California; Orange, California · 11 sites in all
- Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the ReferencePivotal-lookingCompleted
NCT04607746 · 1,337 participants · Start Jan 6, 2021 · Primary completion Feb 14, 2025
Device: Capsule Endoscope · For: Colonic Polyp
Sites: Scottsdale, Arizona; Lancaster, California; Los Gatos, California · 23 sites in all
NCT06916845 · 86 participants · Start Mar 16, 2025 · Primary completion Jun 6, 2025
Device: Colon Capsule · For: Colonic Polyps
Sites: New Port Richey, Florida; Palm Harbor, Florida; Hattiesburg, Mississippi · 4 sites in all
4 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2536-2020 · Started Feb 26, 2020
Reason given: Ingestible video capsule system has capsule with incorrect capture mode which will not record data when the capsule is ingested by patients. If used, there is a risk of delay of diagnosis and the patient may need to repeat the exam.
Cause as FDA categorized it: Employee error · Device type: System, Imaging, Gastrointestinal, Wireless, Capsule (NEZ)
- CapsoCAM Plus, UDI: 00867770000209Terminated
Z-1827-2020 · Started Oct 18, 2019
Reason given: Capsule Endoscopy System: a defect present in the capsule window may be stressed through the production process and in the final package, which could cause the housing of the capsule to crack and leak when ingested. Fluid from the patient could leak in to the capsule, which may damage components inside the capsule and...
Cause as FDA categorized it: Other · Device type: System, Imaging, Gastrointestinal, Wireless, Capsule (NEZ)
Z-2073-2020 · Started Jul 3, 2019
Reason given: Possible mis-labeling of the device with incorrect serial number labels which may result in a patient's misdiagnosis.
Cause as FDA categorized it: Process control · Device type: System, Imaging, Gastrointestinal, Wireless, Capsule (NEZ)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.